Aspire Private Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-220
| Closed | -$26.2K | – | 472 |
|
|
2024
Q3 | $26.2K | Hold |
220
| – | – | 0.01% | 283 |
|
|
2024
Q2 | $31.4K | Buy |
220
+1
| +0.5% | +$143 | 0.01% | 274 |
|
|
2024
Q1 | $28.1K | Buy |
219
+24
| +12% | +$3.08K | 0.01% | 283 |
|
|
2023
Q4 | $20.2K | Sell |
195
-15
| -7% | -$1.55K | 0.01% | 314 |
|
|
2023
Q3 | $19.1K | Sell |
210
-2
| -0.9% | -$182 | 0.01% | 317 |
|
|
2023
Q2 | $17.2K | Sell |
212
-6
| -3% | -$485 | 0.01% | 311 |
|
|
2023
Q1 | $17.3K | Buy |
218
+10
| +5% | +$796 | 0.01% | 303 |
|
|
2022
Q4 | $14.1K | Hold |
208
| – | – | 0.01% | 321 |
|
|
2022
Q3 | $10K | Sell |
208
-8
| -4% | -$385 | ﹤0.01% | 348 |
|
|
2022
Q2 | $12K | Hold |
216
| – | – | ﹤0.01% | 329 |
|
|
2022
Q1 | $12K | Buy |
216
+60
| +38% | +$3.33K | ﹤0.01% | 331 |
|
|
2021
Q4 | $9K | Buy |
156
+32
| +26% | +$1.85K | ﹤0.01% | 352 |
|
|
2021
Q3 | $6K | Hold |
124
| – | – | ﹤0.01% | 361 |
|
|
2021
Q2 | $5K | Sell |
124
-4
| -3% | -$161 | ﹤0.01% | 393 |
|
|
2021
Q1 | $4K | Buy |
128
+120
| +1,500% | +$3.75K | ﹤0.01% | 411 |
|
|
2020
Q4 | $0 | Buy |
8
+2
| +33% | – | ﹤0.01% | 507 |
|
|
2020
Q3 | $0 | Sell |
6
-126
| -95% | – | ﹤0.01% | 497 |
|
|
2020
Q2 | $4K | Buy |
132
+124
| +1,550% | +$3.76K | ﹤0.01% | 240 |
|
|
2020
Q1 | $0 | Sell |
8
-20
| -71% | – | ﹤0.01% | 418 |
|
|
2019
Q4 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 446 |
|